Trade DYAI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Dyadic International, Inc. (DYAI) is trading at US$0.61, down 4.87% today as of Aug 28, 13:00 EDT. The company has a market capitalisation of US$27.64M. Over the past 52 weeks, DYAI has traded between US$0.61 and US$1.60. On Syfe you can trade DYAI with $0 commission and add it to your watchlist.
| Previous close | US$0.64 |
|---|---|
| Market cap | US$27.64M |
| 52-week range | US$0.61 – US$1.60 |
| Volume | 179.25K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dyadic International, Inc.
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
Year: 2004
Dyadic International Progresses Multiple Protein Production Partnerships
Jul 7, 1:32 PM · MT Newswires
Dyadic International Receives Japan Patent Allowance for Recombinant Protein Expression Technology
Jun 29, 12:13 PM · MT Newswires
Dyadic International, Inc. (DYAI) stock is trading at US$0.61, -4.87% from the previous close of US$0.64.
The market cap for Dyadic International, Inc. (DYAI) stock is approximately US$27.64M.
The 52-week high for Dyadic International, Inc. (DYAI) stock is US$1.60.
The 52-week low for Dyadic International, Inc. (DYAI) stock is US$0.61.
Dyadic International, Inc. (DYAI) does not currently pay a dividend.
Stay on top of DYAI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
